JPRN-UMIN000034867
Completed
未知
Impact of 1-month Dual Antiplatelet Therapy After Treatment with Drug-Coated Balloon for Femoropopliteal Artery Disease - 1-month DAPT After Treatment with DCB for Femoropopliteal Artery Lesions
ConditionsArteriosclerosis obliterans
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Arteriosclerosis obliterans
- Sponsor
- Hyogo College of Medicine
- Enrollment
- 151
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who are needed to receive long\-term DAPT Patients who are treated with anticoagulant agent Patients without tolerance to aspirin or clopidogrel
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
One-Month Dual Antiplatelet Therapy followed by P2Y12 Inhibitor Monotherapy After Biofreedom Ultra® Stent Implantation in Patients with Acute Coronary Syndrome: DAPT-FREE TRIAKCT0006530Chonnam National University Hospital1
Recruiting
Not Applicable
Safety and efficacy of 1-month dual antiplatelet therapy in high bleeding and ischemic risk elderly patients with coronary artery disease after implantation of zotarolimus-eluting coronary stent system (Resolute Onyx™ , Medtronic, Minneapolis, MN); A multicenter, prospective, observational studyFactors influencing health status and contact with health servicesKCT0008377Pusan National University Yangsan Hospital500
Not yet recruiting
Not Applicable
Effect of potent P2Y12 inhibitor monotherapy after double antiplatelet therapy for 1 month after PCI in ACS patientsDiseases of the circulatory systemKCT0006861Chonnam National University Hospital2,000
Recruiting
Phase 3
Outcomes of 1-month vs 3-month dual antiplatelet therapy in high bleeding risk patients after percutaneous coronary intervention, a randomized controlled trialTCTR20211024003Faculty of Medicine, Chiang Mai University502
Active, not recruiting
Phase 1
Single versus Dual Antiplatelet Therapy in patients with Incomplete Revascularization after Coronary artery bypass graft surgeryEUCTR2017-001754-33-ITIVERSITÀ CAMPUS BIO-MEDICO DI ROMA800